Section B - Sterile Products I. Definitions - PowerPoint PPT Presentation

About This Presentation
Title:

Section B - Sterile Products I. Definitions

Description:

Prefilled cartridges - (e.g., Tubex, Carpuject) Ready-to-use parenteral packages with a needle that requires a metal or plastic cartridge holder. ... – PowerPoint PPT presentation

Number of Views:992
Avg rating:3.0/5.0
Slides: 25
Provided by: WHBh
Learn more at: http://blue.butler.edu
Category:

less

Transcript and Presenter's Notes

Title: Section B - Sterile Products I. Definitions


1
Section B - Sterile ProductsI. Definitions
  • A. Sterile products
  • B. Sterility
  • C. Aseptic technique
  • D. Parenteral preparations
  • E. Pyrogens
  • F. pH
  • G. Tonicity
  • Isotonic, Hypertonic and Hypotonic solutions
  • Isoosmotic, Hyperosmotic and Hypoosmotic
    solutions

2
Section B - Sterile Products II A. STERILE
PRODUCT PREPARATION AREAS
  • Controlled Area - Usually Class 10,000 or 100,000
    room
  • Critical Area - Usually Hood area Class 100 for
    Rx
  • 1. High-efficiency particulate air (HEPA)
    filters
  • a. HEPA filters remove all airborne
    particles sized 0.3 µm or larger with an
    efficiency of 99.97.

    b. In addition, HEPA-filtered rooms generally are
    classified as
    Federal Class 100,
    1000, 10,000 and 100,000
  • (A class 100 has no more than 100 particles of
    0.5 ?m or larger/cubic ft.)
  • 2. Positive-pressure air flow
  • 3. Counters in the clean room
  • 4. Walls and floors
  • 5. The uniform velocity of the air flow is 90
    ft/min 20

3
Section B - Sterile ProductsII B. Laminar flow
hoods
  • Requirements
  • a. Laminar flow hoods utilize HEPA filters
  • b. Rx Hoods are classified as Federal Class 100
    (class 100 hoods contain no more than 100
    particles sized
    0.5 µm or larger per cubic foot of air)
  • Types
  • Horizontal laminar flow hoods
  • Vertical laminar flow hoods
  • Inspection and Certification
  • at least every 6 to 12 months

4
Section B - Sterile Products
III. STERILIZATION METHODS AND EQUIPMENT
  • A. Thermal sterilization
  • use of either moist or dry heat
  • 1. Moist heat sterilization - an autoclave
  • 121?C, at15 lb. pressure for at least 15
    minutes
  • 2. Dry heat sterilization - an oven
  • at least 160?C for 120 minutes
  • B. Gas sterilization - ethylene oxide
    air, moisture and heat - Quarantine
    period
  • C. Radiation sterilization - ionizing radiation
    - gamma rays

5
III. STERILIZATION METHODS AND EQUIPMENT D.
Mechanical sterilization (filtration)
  • Removes(but does not destroy) micro-organisms and
    clarifies solutions by eliminating particulate
    matter. For solutions rendered unstable by
    thermal, chemical, or radiation sterilization,
    filtration is the preferred method.
  • 1. Depth filters usually consist of fritted glass
    or unglazed porcelain--substances that
    trap particles in channels.
  • 2. Screen (membrane) filters are films measuring
  • 1 to 200 µm thick made of cellulose esters,
    microfilaments, polycarbonate, synthetic
    polymers, silver, or stainless steel.

6
III. STERILIZATION METHODS AND EQUIPMENT D.
Mechanical sterilization (filtration)
  • 2. Screen (membrane) filters
  • Screen Filters are
  • a. A meshwork of millions of microcapillary
    pores of identical size filter the solution
  • by a process of physical sieving.
  • b. Because pores make up 70 to 85 of the
    surface, screen filters have a higher
  • flow rate than depth filters.
  • c. Screen filters come in three basic types.

7
III. STERILIZATION METHODS AND EQUIPMENT D.
Mechanical sterilization (filtration) THREE
TYPES OF SCREEN FILTERS
  • Particulate filters remove particulates of glass,
    plastic, rubber, and other contaminants. The pore
    size of standard particulate filters ranges from
    0.45 to 5 µm. (special sizes for blood fat
    emulsions)
  • Microbial filters, with a pore size of 0.22 µm or
    smaller, ensure complete microbial removal or
    sterilization.
  • Final filters, which may be either particulate or
    microbial, are in-line filters used to remove
    particulates or micro-organisms from an
    intravenous (IV) solution before infusion.

8
Section B - Sterile Products IV. PACKAGING OF
PARENTERAL PRODUCTS
  • Parenteral preparations and other sterile
    products must be packaged in a way that maintains
    product sterility until time of use and prevents
    contamination of contents during opening.
  • Types of containers
  • Ampoules the oldest type of parenteral product
    containers, are made entirely of glass.
    Intended for single use only
  • Vials are glass or plastic containers closed
    with a rubber stopper and sealed with an
    aluminum crimp.
  • Advantages and Disadvantages
  • of these containers

9
IV. PACKAGING OF PARENTERAL PRODUCTS Advantages
and DisadvantagesVials and Ampoules
  • Advantages over ampoules
  • 1. They can be designed to hold multiple doses
  • 2. It is easier to remove the product.
  • 3. They eliminate the risk of glass particle
    contamination during opening.
  • Disadvantages over ampoules
  • 1. The rubber stopper may become cored.
  • 2. Multiple withdrawals may result in
    contamination.
  • 3. Stability - Reaction with rubber and plastic

10
IV. PACKAGING OF PARENTERAL PRODUCTS Prefilled
Containers
  • Prefilled syringes - (e.g., Abboject, Bristoject)
    Drugs administered in an emergency (e.g.,
    epinephrine, atropine, ) are available for
    immediate injection.
  • Prefilled cartridges - (e.g., Tubex, Carpuject)
    Ready-to-use parenteral packages with a needle
    that requires a metal or plastic cartridge
    holder.
  • Infusion solutions - two categories small
    volume parenterals (SVP), those having a volume
    less than 100 ml(in practice 100 ml or less)
    large volume parenterals (LVP), those having a
    volume of 100 ml or greater. (in practice gt100
    ml)

11
IV. PACKAGING OF PARENTERAL PRODUCTS Packaging
materials
  • Glass and plastic polymers
  • Glass, the original parenteral packaging
    material. Glass is Silicon dioxide(sand) with
    metallic oxide. Boron oxide, earth alkaline
    oxides(Ca, Na, K etc.) and metal oxides for color
    - manganese for amber.
  • Type I. Borosilicate glass - most resistant and
    least reactive - sterilize either before or
    after.
  • Type II. Soda-Lime glass - treated with acid gas
    - must sterilize before by dry heat
  • Type III. Soda-Lime glass - least used - must
    sterilize before.

12
IV. PACKAGING OF PARENTERAL PRODUCTS Plastic
polymers
  • Plastics - Polyvinylchloride (PVC) and Polyolefin
  • PVC is flexible and non-rigid
  • Polyolefin is semi-rigid and can be stored
    upright
  • Chemicals added to plastic containers
  • Stabilizers - protect from light and
    discoloration
  • Accelerators - increases rate of polymerization
  • Antioxidants - retard oxidation
  • Fillers - modify physical properties
  • Lubricants - to ease molding
  • Colorants - add color

13
IV. PACKAGING OF PARENTERAL PRODUCTS Rubber
Closures Composition
  • Rubber (natural) neoprene or butyl base polymer
  • Vulcanizing agents - sulfur - reduces plasticity,
    resist temp changes.
  • Accelerators - sulfides/guanidine - increase
    vulcanization rate
  • Activators - zinc oxide - activate accelerators
  • Fillers - carbon black/kaolin - strength and
    hardness
  • Plasticizers - dibutyl phathalate - flexibility
  • Antioxidants - aromatic amines - retard oxidation

14
V. PARENTERAL ADMINISTRATION ROUTES
  • Site volume in ml
    needle type
  • Intradermal-------- 0.1 ml ---------24 -25 G, 1/4
    - 5/8?
  • Subcutaneous----1.0 ml ---------15 -25 G, 1/4 -
    5/8?
  • Intramuscular ---- 2.0 ml (5 max)---- 19 - 22 G,
    1 - 2?
  • Intravenous ------ no limit -----------15 - 25 G,
    1 - 2?
  • Intra-arterial ----- no limit ---------- 15 - 25
    G, 1 - 2?
  • Intracardiac ------ 10 ml (50 max ) ----18 - 21
    G, 3 1/2?
  • Intraperitoneal -- ------14 G, 4 - 6?
  • Intraspinal -- ------20 - 22G, 3 - 5?
  • Intrathorasic ----- 13 G, 5 - 6?

15
VI. NEEDLES and SYRINGES Hypodermic needles
are stainless steel or aluminum devices that
penetrate the skin for the purpose of
administering or transferring a parenteral
product.
  • Needle gauge refers to the outside diameter of
    the needle shaft the larger the number, the
    smaller the diameter
  • Needle lengths range from 1/4 to 6 inches.
    Choice of needle length depends on the desired
    penetration
  • Bevels are slanting edges cut into needle tips to
    facilitate injection through tissue or rubber
    vial closures. a. Regular-bevel needles are the
    most commonly used type suitable for SQ and IM
    injections b. Short-bevel needles are used
    when only shallow penetration is required (as
    in IV injections). c. Intradermal-bevel needles
    are designed for ID injections

16
VI. NEEDLES and SYRINGES Syringes are devices
for injecting, withdrawing, or instilling fluids.
Made of reusable glass and plastic
  • Syringe volumes range from 0.3 to 60 mL.
  • Syringe Parts 1. a glass or plastic barrel 2. a
    tight-fitting plunger at one end 3. a small
    opening at the other end accommodates the head of
    a needle.
  • Calibrations metric or English system, vary in
    specificity depending on syringe size the
    smaller the syringe, the more specific the
    scale.Insulin syringes have unit gradations (40
    or 100 units/m) rather than volume gradations.
  • Syringe tips come in several types.Luer-Lok tips
    are threaded to ensure that the needle fits
    tightly in the syringe. Luer-Slip tips are
    unthreaded. Needle is held by friction and is not
    lock into place.
  • Eccentric tips, set off center, allow the needle
    to remain parallel to the injection
    site.Catheter tips are used for wound irrigation
    and administration of enteral feedings. Not
    intended for injection.

17
VII. PARENTERAL DRUG DELIVERY
  • A. Injection sites
  • 1. Peripheral vein injection is preferred for
    drugs that do not irritate the veins and for
    short-term IV therapy. Generally, the dorsal
    forearm surface is chosen for venipuncture.
  • 2. Central vein injection is preferred for
    administration of irritating drugs or
    hypertonic solutions for long-term IV therapy,
    and when a peripheral line cannot be maintained.
    Large veins in the thoracic cavity, such as the
    subclavian, are used.
  • B. Infusion methods
  • 1. Continuous drip infusion is the slow,
    primary-line infusion. Provide fluid and
    electrolyte replacement.
  • 2. Intermittent infusion allows drug
    administration at specific intervals. Four
    different techniques may be used.

18
VII. PARENTERAL DRUG DELIVERY Intermittent
Infusion Techniques
  • a. Direct (bolus) injection - delivers small
    volumes of a drug.
  • b. Additive set infusion - use of a
    volume-control device for delivery of small
    amounts of IV solutions or diluted medications.
    The fluid chamber is attached to an independent
    fluid supply or placed directly under the
    established primary IV line.
  • c. Piggyback method - A special coupling method
    for the primary IV tubing permitting the infusion
    of a piggyback drug solution.
  • d. intermittent infusion injection devices -
    Also called scalp-vein, heparin-lock, or
    butterfly infusion sets, these devices permit
    intermittent delivery while eliminating the need
    for multiple venipunctures or prolonged venous
    access with a continuous infusion.A heparin flush
    set must be used to maintain the line.(Set 1 ml
    NS - 0.5 ml Heparin - 1 ml NS)

19
VII. PARENTERAL DRUG DELIVERY Pumps and
ControllersPumps and controllers are used to
administer parenteral infusions with accuracy and
safety.
  • Pumps - Electronic devices, Piston-cylinder
    Peristaltic Mechanisms.
  • Controllers, unlike pumps, exert no pumping
    pressure on the fluid. The infusion is by
    gravity and the controller counts the infusion
    drops electronically
  • Types of pumps and controllers
  • a. Volumetric pumps and controllers. Combination
    is most
  • commonly used for both intermittent and
    continuous infusions..
  • b. Syringe pumps.- Selective use - in pain
    management and pediatrics
  • c. Mobile infusion pump - small infusion devices
    designed for ambulatory and home healthcare
    patients.
  • d. Implantable devices - infusion devices
    surgically placed under the skin to provide a
    continuous release of medication.

20
VIII. PARENTERAL PREPARATIONS
  • Primary Parenteral Fluids
  • For preparation and administration of parenteral
    products
  • Sterile Water For Injection (SWFI) - For
    preparation only
  • Bacteriostatic Water For Injection (BWFI) - For
    preparation only
  • Normal Saline Solution (NS) - For both
    (preparation administration)
  • Dextrose 5 in Water (D5W) - For both
    (preparation administration)
  • Ringers Solution (R) - For administration only
  • Lactated Ringers Solution (LR) - For
    administration only
  • Combination Parenteral Fluids
  • D5/NS, D5/1/2 NS, D5/1/4 NS and D2.5/1/2 NS
  • D5/R, D5/LR

21
Parenteral Antineoplasic PreparationsSpecial
Training Required
  • Special Documented Training
  • Proper handling, preparation, administration,
    disposal
  • and spill cleaning training of highly toxic
    drugs.
  • Garments - use gown, shoe cover, mask, gloves,
    hair cover and
  • goggles as specified. Proper attire is required
    for these drugs.
  • Handling - record and check all drug containers.
  • Preparation - only in vertical laminar flow hood.
  • Must use spill mats in hood. Use either chemo
    spike or negative pressure during preparation.
  • Administration - infusion set, if needed, must be
    primed in the hood.
  • Disposal - dispose all material in special
    containers.
  • Spill Cleaning - must follow team training
    procedures.

22
IX. PARENTERAL INCOMPATIBILITIES
  • Types of Incompatibilities
  • 1. Physical incompatibility - visible change in
    solution appearance.
  • 2. Chemical incompatibility - chemical change
    resulting in either toxicity or therapeutic
    inactivity which is not always visible.
  • Chemical Changes occur due to
  • Complexation, Oxidation, Reduction, Photolysis
  • 3. Therapeutic incompatibility - Change in
    activity of one with others.
  • Factors affecting IV compatibility
  • pH , Temperature, Time, Dilution, Mixing order
  • Preventing or minimizing incompatibilities
  • Practical Control of all factors which lead to
    incompatibilities

23
X. QUALITY CONTROL AND QUALITY ASSURANCE
  • Definitions
  • Quality control is the day-to-day assessment of
    all operations including analytic testing of the
    finished product.
  • Quality assurance, an oversight function,
    involves the auditing of quality control
    procedures and systems, with changes as needed.
  • USP Tests
  • Sterility Test - Microbial Growth Promotion
    Test.
  • Pyrogen Test - Rabbit Temperature Test.
  • Endotoxin Test - LAL(Limulus Amebocyte Lysate)
    Test.
  • Particulate Test - Microscopic Particle Count
    Test.

24
Sterile Product Section B
END
Write a Comment
User Comments (0)
About PowerShow.com